Evidence map›Paper›PMID 37593727›Full record

ArticleFrontiers in public health2023

TheiaEuk: a species-agnostic bioinformatics workflow for fungal genomic characterization.

Frank J Ambrosio, Michelle R Scribner, Sage M Wright, James R Otieno, Emma L Doughty, Andrew Gorzalski, Danielle Denise Siao, Steve Killian, Chi Hua, Emily Schneider and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. [Diagnostic Performance of Metagenomic Next-Generation Sequencing for Mucormycosis: A Retrospective Cohort Study].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  4. Review
  5. Acquired amphotericin B resistance attributed to a mutatedAntimicrobial agents and chemotherapy · 2025
    Article
  6. Genetic Confirmation of Clonal Spread ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  7. Acquired Amphotericin B Resistance Attributed to a MutatedbioRxiv : the preprint server for biology · 2025
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Frank J AmbrosioTheiagen Genomics, Highlands Ranch, CO, United States.
Michelle R ScribnerTheiagen Genomics, Highlands Ranch, CO, United States.
Sage M WrightTheiagen Genomics, Highlands Ranch, CO, United States.
James R OtienoTheiagen Genomics, Highlands Ranch, CO, United States.
Emma L DoughtyTheiagen Genomics, Highlands Ranch, CO, United States.
Andrew GorzalskiNevada State Public Health Laboratory, Reno, NV, United States.
Danielle Denise SiaoNevada State Public Health Laboratory, Reno, NV, United States.
Steve KillianAlameda County Public Health Laboratory, Oakland, CA, United States.
Chi HuaPublic Health Laboratories, Division of Disease Control and Health Statistics, Washington State Department of Health, Shoreline, WA, United States.
Emily SchneiderPublic Health Laboratories, Division of Disease Control and Health Statistics, Washington State Department of Health, Shoreline, WA, United States.
Michael TranPublic Health Laboratories, Division of Disease Control and Health Statistics, Washington State Department of Health, Shoreline, WA, United States.
Vici VargheseAlameda County Public Health Laboratory, Oakland, CA, United States.
Kevin G LibuitTheiagen Genomics, Highlands Ranch, CO, United States.
Mark PandoriNevada State Public Health Laboratory, Reno, NV, United States.
Joel R SevinskyTheiagen Genomics, Highlands Ranch, CO, United States.
David HessNevada State Public Health Laboratory, Reno, NV, United States.
Nevada Division of Public and Behavioral Health · USWashington State Department of Health · USAlameda County Public Health Department · USUniversity of Nevada, Reno · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The clinical incidence of antimicrobial-resistant fungal infections has dramatically increased in recent years. Certain fungal pathogens colonize various body cavities, leading to life-threatening bloodstream infections. However, the identification and characterization of fungal isolates in laboratories remain a significant diagnostic challenge in medicine and public health. Whole-genome sequencing provides an unbiased and uniform identification pipeline for fungal pathogens but most bioinformatic analysis pipelines focus on prokaryotic species. To this end, TheiaEuk_Illumina_PE_PHB (TheiaEuk) was designed to focus on genomic analysis specialized to fungal pathogens. Methods: TheiaEuk was designed using containerized components and written in the workflow description language (WDL) to facilitate deployment on the cloud-based open bioinformatics platform Terra. This species-agnostic workflow enables the analysis of fungal genomes without requiring coding, thereby reducing the entry barrier for laboratory scientists. To demonstrate the usefulness of this pipeline, an ongoing outbreak of Results: A primary result of this work is a curated fungal database containing 5,667 unique genomes representing 245 species. TheiaEuk also incorporates taxon-specific submodules for specific species, including clade-typing for Discussion: TheiaEuk demonstrated effectiveness in identifying fungal species from whole genome sequence. It further showed accuracy in both clade-typing of

Indexed as

Computational BiologyGenome, FungalDisease OutbreaksGenomicsWorkflowbioinformaticsCandida aurisemerging pathogensepidemiologywhole-genome sequencing

Identifiers

PMID37593727
PMCPMC10428623
OpenAlexW4385461865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.